Effect of Fennel on Depression and Anxeity of Postmenopausal Women

Comparison of Fennel and Placebo efficacy on Depression and Anxiety of Postmenopausal Women that referred to menopausal Clinic of Imam Reza Hospital of Mashhad

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016072629097N1

Enrollment

Registered

2016-12-25

Start date

2016-06-18

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause. Menopausal and female climacteric states

Interventions

Intervention 1: phenelin 21-27 mg in a capsule. 3 month, tds. Intervention 2: placebo.3month.tds.

Treatment - Drugs

Placebo

phenelin 21-27 mg in a capsule. 3 month, tds

placebo.3month.tds

Eligibility

Sex/Gender

Female

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: postmenopausal status which was defined as aged over 40 years with no vaginal bleeding for 1 year? no regular ingestion of phytoestrogen or soy-based products? having a normal mammogram in the last year. The exclusion criteria: Currently (or in the past 6 months) using estrogen or calcitonin? any history of endometrial or breast cancer? no regular physical exercise or allergy to Foeniculum vulgare.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Zung Self-rating Depression Scale. Timepoint: before intervention, 12 weeks after intervention. Method of measurement: The Zung Self-rating Depression Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Afiat

Mashhad University of Medical Sciences

afiatm@mums.ac.ir+98 915 505 6897

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026